Cano Health, Inc.
CANO · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $670 | $4,238 | $2,229 | $831 |
| - Cash | $27 | $163 | $34 | $29 |
| + Debt | $1,200 | $1,065 | $465 | $0 |
| Enterprise Value | $1,842 | $5,141 | $2,661 | $802 |
| Revenue | $2,739 | $1,609 | $832 | $361 |
| % Growth | 70.2% | 93.5% | 130.1% | – |
| Gross Profit | $422 | $199 | $165 | $77 |
| % Margin | 15.4% | 12.4% | 19.9% | 21.2% |
| EBITDA | -$198 | -$49 | -$18 | $18 |
| % Margin | -7.2% | -3% | -2.2% | 4.9% |
| Net Income | -$428 | -$117 | -$71 | -$30 |
| % Margin | -15.6% | -7.3% | -8.5% | -8.2% |
| EPS Diluted | -87.6 | -24.54 | -42.75 | -17.86 |
| % Growth | -257% | 42.6% | -139.4% | – |
| Operating Cash Flow | -$146 | -$129 | -$9 | -$15 |
| Capital Expenditures | -$50 | -$34 | -$12 | -$9 |
| Free Cash Flow | -$196 | -$163 | -$21 | -$25 |